IL6 and COVID-19: Clinical data (Feng X. et al., 2020; Chen et al., 2020; Wang et al., 2021a) have shown that COVID-19 patients, especially severe patients, experienced significantly elevated systemic levels of IL-6 compared to healthy controls.